SAN DIEGO, April 17, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), a global leader in the transformation of the cytogenetic workflow with OGM, today announced that it has entered into an ...
Dutch-French research shows that Optical Genome Mapping (OGM) detects abnormalities in chromosomes and DNA very quickly, effectively and accurately. Sometimes even better than all existing techniques ...
LONDON--(BUSINESS WIRE)--Technavio’s latest market research report on the global molecular cytogenetics market provides an analysis of the most important trends expected to impact the market outlook ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 1 of the Bionano Symposium 2026 entitled Advancements in Hematologic Malignancies with Optical Genome Mapping (OGM).
Implementing the International Prognostic Scoring System-Molecular (IPSS-M) in clinical practice could impact clinical management for nearly half of patients with myelodysplastic syndromes (MDS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results